Skip to main content
Top
Published in: Clinical Rheumatology 1/2021

01-01-2021 | Knee Osteoarthritis | Original Article

Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis

Authors: Sicong Min, Tianshu Shi, Xiao Han, Dongyang Chen, Zhihong Xu, Dongquan Shi, Huajian Teng, Qing Jiang

Published in: Clinical Rheumatology | Issue 1/2021

Login to get access

Abstract

Objective

To investigate the relationship between leptin, osteopontin (OPN), sclerostin (SOST) and severity of knee osteoarthritis (KOA).

Methods

The study included 148 consecutive patients with knee OA and 101 non-KOA subjects enrolled in this cross-sectional study. All patients fulfilled the American College of Rheumatology criteria for primary knee OA. Severity of the disease was assessed using plain radiography of the affected knee, according to the Kellgren and Lawrence classification. Fasting blood samples were obtained from all patients and controls; the serum samples were kept at − 80 °C before assessment of leptin, OPN, and SOST using a multiplex particle-based flow cytometric assay.

Results

KOA patients group compared with the control group, serum leptin (KOA, 26581.7 ± 2011.5 pg/ml, vs control,6936.4 ± 702.2 pg/ml),OPN (KOA, 4908.3 ± 769.4 pg/ml, vs control, 2182.5 ± 217.8 pg/ml), and SOST (KOA, 2481.9 ± 543.5 pg/ml, vs control, 1288.9 ± 267.7 pg/ml) in the KOA group were higher than control group; there were also differences in three bone metabolic factors between male and female in the KOA group; meanwhile, there was correlation between each factor and the incidence of KOA.

Conclusion

Our study of 249 serum samples was conducted. Serum leptin, OPN, and SOST were significantly increased in KOA patients, and there was an internal correlation; these findings could, at best, contribute to the identification of novel targets for medical interventions.
Key Points
The aim of this study was to assess the relationships of radiographic knee OA with altered serum levels of leptin, OPN, and SOST. Our study of 249 serum samples was conducted. Serum leptin, OPN, and SOST were significantly increased in KOA patients compared with control group. There were gender differences in the concentration of three serum bone turnover factors in KOA group and control group. Serum SOST concentration increased with Kellgren-Lawrence (K-L) grading. We found that serum leptin, OPN, and SOST were significantly increased in KOA patients, and there was an internal correlation. Leptin had a remarkable diagnostic value in the incidence of KOA.
Literature
1.
go back to reference Felson DT, Dsc YZ, Hannan MT, Naimark A, Levy D (1995) The incidence and natural history of knee osteoarthritis in the elderly. The Framingham osteoarthritis study. Arthritis Rheum 38(10):1500–1505CrossRef Felson DT, Dsc YZ, Hannan MT, Naimark A, Levy D (1995) The incidence and natural history of knee osteoarthritis in the elderly. The Framingham osteoarthritis study. Arthritis Rheum 38(10):1500–1505CrossRef
2.
go back to reference Leung GJ, Rainsford KD, Kean WF (2014) Osteoarthritis of the hand I: aetiology and pathogenesis, risk factors, investigation and diagnosis. J Pharm Pharmacol 66(3):339–346CrossRef Leung GJ, Rainsford KD, Kean WF (2014) Osteoarthritis of the hand I: aetiology and pathogenesis, risk factors, investigation and diagnosis. J Pharm Pharmacol 66(3):339–346CrossRef
3.
go back to reference Garnero P (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60(6):619–626CrossRef Garnero P (2001) Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis 60(6):619–626CrossRef
4.
go back to reference Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR et al (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a mepe-asarm-dependent mechanism. J Bone Miner Res 26(7) Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR et al (2011) Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a mepe-asarm-dependent mechanism. J Bone Miner Res 26(7)
5.
go back to reference Blom AB, Peter LVL, Peter MVDK, Wim BVDB (2010) To seek shelter from the wnt in osteoarthritis? Wnt-signaling as a target for osteoarthritis therapy. Curr Drug Targets 11(5):620–629CrossRef Blom AB, Peter LVL, Peter MVDK, Wim BVDB (2010) To seek shelter from the wnt in osteoarthritis? Wnt-signaling as a target for osteoarthritis therapy. Curr Drug Targets 11(5):620–629CrossRef
6.
go back to reference Bouaziz W, Funck-Brentano T, Lin H, Marty C, Ea HK, Hay E, Cohen-Solal M (2015) Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent wnt pathways. Arthritis Res Ther 17(1):24CrossRef Bouaziz W, Funck-Brentano T, Lin H, Marty C, Ea HK, Hay E, Cohen-Solal M (2015) Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent wnt pathways. Arthritis Res Ther 17(1):24CrossRef
8.
go back to reference Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. 72(Supplement 30):92–102 Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. 72(Supplement 30):92–102
9.
go back to reference Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR (2001) Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44(3):578–584CrossRef Attur MG, Dave MN, Stuchin S, Kowalski AJ, Steiner G, Abramson SB, Denhardt DT, Amin AR (2001) Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44(3):578–584CrossRef
10.
go back to reference Pullig O, Weseloh G, Gauer S, Swoboda B (2000) Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol J Int Soc Matrix Biol 19(3):245–255CrossRef Pullig O, Weseloh G, Gauer S, Swoboda B (2000) Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol J Int Soc Matrix Biol 19(3):245–255CrossRef
11.
go back to reference Green ED, Maffei M, Braden VV, Proenca R, Desilva U, Zhang Y et al (1995) The human obese (Ob) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 5(1):5–12CrossRef Green ED, Maffei M, Braden VV, Proenca R, Desilva U, Zhang Y et al (1995) The human obese (Ob) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 5(1):5–12CrossRef
12.
go back to reference Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL et al (2001) Leptin activates anorexigenic pomc neurons through a neural network in the arcuate nucleus. Nature 411(6836):480–484CrossRef Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL et al (2001) Leptin activates anorexigenic pomc neurons through a neural network in the arcuate nucleus. Nature 411(6836):480–484CrossRef
13.
go back to reference Liang J, Feng J, Wu WKK, Xiao J, Wu Z, Han D, Zhu Y, Qiu G (2011) Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the rhoa/rock pathway. J Orthop Res 29(3):369–374CrossRef Liang J, Feng J, Wu WKK, Xiao J, Wu Z, Han D, Zhu Y, Qiu G (2011) Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the rhoa/rock pathway. J Orthop Res 29(3):369–374CrossRef
14.
go back to reference Scotece M, Conde J, López V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O (2014) Adiponectin and leptin: new targets in inflammation. Basic Clin Pharmacol Toxicol 114(1):97–102CrossRef Scotece M, Conde J, López V, Lago F, Pino J, Gómez-Reino JJ, Gualillo O (2014) Adiponectin and leptin: new targets in inflammation. Basic Clin Pharmacol Toxicol 114(1):97–102CrossRef
15.
go back to reference Altman RD, Asch E, Bloch DA, Bole G, Hochberg M (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum 29(8):1039–1049CrossRef Altman RD, Asch E, Bloch DA, Bole G, Hochberg M (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum 29(8):1039–1049CrossRef
16.
go back to reference Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16(4):494–502 Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16(4):494–502
17.
go back to reference Karvonen-Gutierrez CA, Harlow SD, Mancuso P, Jacobson J, Mendes de Leon CF, Nan B (2013) Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women. Arthritis Care Res 65(6):936–944CrossRef Karvonen-Gutierrez CA, Harlow SD, Mancuso P, Jacobson J, Mendes de Leon CF, Nan B (2013) Association of leptin levels with radiographic knee osteoarthritis among a cohort of midlife women. Arthritis Care Res 65(6):936–944CrossRef
18.
go back to reference Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS (1996) Role of leptin in the neuroendocrine response to fasting. Nature (London) 382(6588):250–252CrossRef Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS (1996) Role of leptin in the neuroendocrine response to fasting. Nature (London) 382(6588):250–252CrossRef
19.
go back to reference Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21(8):1401–1409CrossRef Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21(8):1401–1409CrossRef
20.
go back to reference Ardawi M-SM, Al-Kadi HA, Rouzi AA et al (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26(12) Ardawi M-SM, Al-Kadi HA, Rouzi AA et al (2011) Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res 26(12)
21.
go back to reference Cicuttini FM, Baker JR, Spector TD (1996) The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23:1221–1226PubMed Cicuttini FM, Baker JR, Spector TD (1996) The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol 23:1221–1226PubMed
22.
go back to reference Iliopoulos D, Malizos KN, Tsezou A (2007) Epigenetic regulation of leptin affects mmp-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66(12):1616–1621CrossRef Iliopoulos D, Malizos KN, Tsezou A (2007) Epigenetic regulation of leptin affects mmp-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66(12):1616–1621CrossRef
23.
go back to reference Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K (1995) Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44(7):855–858CrossRef Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K (1995) Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44(7):855–858CrossRef
24.
go back to reference Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T (1995) Effects of the obese gene product on body weight regulation in Ob/Ob mice. Science 269(5223):540–543CrossRef Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T (1995) Effects of the obese gene product on body weight regulation in Ob/Ob mice. Science 269(5223):540–543CrossRef
25.
go back to reference Zhang P, Zhong ZH, Yu HT, Liu B (2015) Significance of increased leptin expression in osteoarthritis patients. PLoS One:10 Zhang P, Zhong ZH, Yu HT, Liu B (2015) Significance of increased leptin expression in osteoarthritis patients. PLoS One:10
26.
go back to reference Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P et al (2014) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48(11):3118–3129CrossRef Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P et al (2014) Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 48(11):3118–3129CrossRef
27.
go back to reference Scotece M, Mobasheri A et al (2015) Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci 140:S0024320515003161CrossRef Scotece M, Mobasheri A et al (2015) Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci 140:S0024320515003161CrossRef
28.
go back to reference Yang Y, Gao SG, Zhang FJ, Luo W, Lei GH (2014) Effects of osteopontin on the expression of il-6 and il-8 inflammatory factors in human knee osteoarthritis chondrocytes. Cell Biochem Biophys Yang Y, Gao SG, Zhang FJ, Luo W, Lei GH (2014) Effects of osteopontin on the expression of il-6 and il-8 inflammatory factors in human knee osteoarthritis chondrocytes. Cell Biochem Biophys
29.
go back to reference Yusheng L, Wenfeng X, Minghua S, Zhenhan D, Chao Z, Hui L et al (2016) The expression of osteopontin and wnt5a in articular cartilage of patients with knee osteoarthritis and its correlation with disease severity. Biomed Res Int 2016:1–7 Yusheng L, Wenfeng X, Minghua S, Zhenhan D, Chao Z, Hui L et al (2016) The expression of osteopontin and wnt5a in articular cartilage of patients with knee osteoarthritis and its correlation with disease severity. Biomed Res Int 2016:1–7
30.
go back to reference Mohammed FI, Abd El-Azeem MI, Kamaleldin AM (2012) Plasma and synovial fluid osteopontin levels in patients with knee osteoarthritis: relation to radiological grade. Egypt Rheumatol 34(3):131–136CrossRef Mohammed FI, Abd El-Azeem MI, Kamaleldin AM (2012) Plasma and synovial fluid osteopontin levels in patients with knee osteoarthritis: relation to radiological grade. Egypt Rheumatol 34(3):131–136CrossRef
31.
go back to reference Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P (2009) Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42(9):808–812CrossRef Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P (2009) Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42(9):808–812CrossRef
32.
go back to reference Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil 18(1):82–87CrossRef Gao SG, Li KH, Zeng KB, Tu M, Xu M, Lei GH (2010) Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients. Osteoarthr Cartil 18(1):82–87CrossRef
33.
go back to reference Mödder UI, Hoey KA, Amin S, Mccready LK, Achenbach SJ, Riggs BL et al (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373–379CrossRef Mödder UI, Hoey KA, Amin S, Mccready LK, Achenbach SJ, Riggs BL et al (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373–379CrossRef
34.
go back to reference Semenov M, Tamai K, He X (2005) SOST is a ligand for lrp5/lrp6 and a wnt signaling inhibitor. J Biol Chem 280(29):26770–26775CrossRef Semenov M, Tamai K, He X (2005) SOST is a ligand for lrp5/lrp6 and a wnt signaling inhibitor. J Biol Chem 280(29):26770–26775CrossRef
35.
go back to reference Moustafa A, Sugiyama T, Prasad J, Zaman G, Gross TS, Lanyon LE, Price JS (2012) Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered. Osteoporos Int 23(4):1225–1234CrossRef Moustafa A, Sugiyama T, Prasad J, Zaman G, Gross TS, Lanyon LE, Price JS (2012) Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered. Osteoporos Int 23(4):1225–1234CrossRef
36.
go back to reference Robling AGA, Niziolek PJP, Baldridge LAL, Condon KWK, Allen MRM, Alam II et al (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of SOST/sclerostin. J Biol Chem 283(9):5866–5875CrossRef Robling AGA, Niziolek PJP, Baldridge LAL, Condon KWK, Allen MRM, Alam II et al (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of SOST/sclerostin. J Biol Chem 283(9):5866–5875CrossRef
37.
go back to reference Wanby P, Nobin R, Von SP, Brudin L, Carlsson M (2016) Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin d in swedish geriatric patients aged 75?Years or older with a fresh hip fracture and in healthy controls. J Endocrinol Investig 39:855–863CrossRef Wanby P, Nobin R, Von SP, Brudin L, Carlsson M (2016) Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin d in swedish geriatric patients aged 75?Years or older with a fresh hip fracture and in healthy controls. J Endocrinol Investig 39:855–863CrossRef
Metadata
Title
Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis
Authors
Sicong Min
Tianshu Shi
Xiao Han
Dongyang Chen
Zhihong Xu
Dongquan Shi
Huajian Teng
Qing Jiang
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 1/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05150-z

Other articles of this Issue 1/2021

Clinical Rheumatology 1/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.